These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24256258)

  • 1. Endocannabinoid signalling in Alzheimer's disease.
    Maroof N; Pardon MC; Kendall DA
    Biochem Soc Trans; 2013 Dec; 41(6):1583-7. PubMed ID: 24256258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    Altamura C; Ventriglia M; Martini MG; Montesano D; Errante Y; Piscitelli F; Scrascia F; Quattrocchi C; Palazzo P; Seccia S; Vernieri F; Di Marzo V
    J Alzheimers Dis; 2015; 46(2):497-506. PubMed ID: 25818503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals?
    López-Gómez L; Szymaszkiewicz A; Zielińska M; Abalo R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate.
    Sánchez-Sanz A; Posada-Ayala M; Sabín-Muñoz J; Fernández-Miranda I; Aladro-Benito Y; Álvarez-Lafuente R; Royuela A; García-Hernández R; la Fuente OR; Romero J; García-Merino A; Sánchez-López AJ
    Sci Rep; 2022 Nov; 12(1):20300. PubMed ID: 36434122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease.
    Bedse G; Romano A; Lavecchia AM; Cassano T; Gaetani S
    J Alzheimers Dis; 2015; 43(4):1115-36. PubMed ID: 25147120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
    Bari M; Rapino C; Mozetic P; Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.
    Re G; Barbero R; Miolo A; Di Marzo V
    Vet J; 2007 Jan; 173(1):21-30. PubMed ID: 16324856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.
    Sailler S; Schmitz K; Jäger E; Ferreiros N; Wicker S; Zschiebsch K; Pickert G; Geisslinger G; Walter C; Tegeder I; Lötsch J
    Oncoscience; 2014; 1(4):272-282. PubMed ID: 25594019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
    Karl T; Cheng D; Garner B; Arnold JC
    Expert Opin Ther Targets; 2012 Apr; 16(4):407-20. PubMed ID: 22448595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
    Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
    Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and nutrition.
    Hansen HS; Artmann A
    J Neuroendocrinol; 2008 May; 20 Suppl 1():94-9. PubMed ID: 18426507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system in neuropathological states.
    Orgado JM; Fernández-Ruiz J; Romero J
    Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid system in neurodegeneration: new perspectives in Alzheimer's disease.
    Campillo NE; Páez JA
    Mini Rev Med Chem; 2009 May; 9(5):539-59. PubMed ID: 19456285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
    Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
    Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
    O'Sullivan SE; Kendall DA
    Immunobiology; 2010 Aug; 215(8):611-6. PubMed ID: 19833407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility.
    Karasu T; Marczylo TH; Maccarrone M; Konje JC
    Hum Reprod Update; 2011; 17(3):347-61. PubMed ID: 21227997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.